Back To Schedule
Monday, June 15 • 10:15am - 10:45am
#101 SL-CH: Challenges in Advanced Therapy Development: A New Community

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Component Type: Workshop
Level: Intermediate

Advanced therapies face very unique challenges at every stage of development and beyond marketing. DIA is launching a new Advanced Therapy Community to facilitate cross-functional discussion of every aspect of advanced therapy development.

Learning Objectives

Identify the complexity and challenges of advanced therapy development from the preclinical conception throughout clinical development through development and post-approval cost and monitoring implications; Discuss the benefit of joining the new Advanced Therapy Community and attending the monthly online meetings.


Kirsten Messmer, PhD, RAC


Richard Dennett, DrSc

avatar for Kirsten Messmer

Kirsten Messmer

Principal Regulatory Affairs Specialist, PPD
Kirsten Messmer, PhD, RAC, is a Principal Regulatory Affairs Specialist in the Regulatory Intelligence Solutions team at PPD which provides regulatory intelligence to clients and departments within PPD to support drug development and clinical research. Prior to joining PPD she completed... Read More →
avatar for Richard Dennett

Richard Dennett

Senior Director Regulatory Affairs CMC, PPD
Richard Dennett heads the Regulatory Affairs CMC activities at PPD and provides expertise, technical guidance & leadership for global CMC regulatory strategy. He additionally chairs PPD’s Advanced Therapy Forum. Richard has held several strategic product development roles including... Read More →

Monday June 15, 2020 10:15am - 10:45am EDT
TBD Virtual Event Horsham, PA 19044